Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James Boyd, MD
University of Vermont / United States Principal Investigator
Principal Investigator - Wolfgang Oertel, MD
Philipps-University Marburg, Germany / Global and German Principal Investigator
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universitatsklinikum Giessen U. Marburg Gmbh
Standort Marburg, Marburg, Germany
- Charite Campus Virchow Klinikum
Berlin, Germany
- Klinikum Bremerhaven
Bremerhaven, Germany
- Universitaetsklinikum Carlgustav Carus
Dresden, Germany
- Neurologische Klinik Der, Dusseldorf
Düsseldorf, Germany
- Neurologische Universitaetsklinik Freiburg
Freiburg im Breisgau, Germany
- Klinikum Hanau Gmbh
Hanau, Germany
- Universitaetsklinikum Des Saarlandes
Homburg/Saar, Germany
- Paracelsus-Elena-Klinik Kassel
Kassel, Germany
- Universitaetsklinikum Schlewsig-Holstein
Kiel, Germany
- Universitaetsklinikum Leipzig
Leipzig, Germany
- Otto-Von-Guericke-Universitat
Magdeburg, Germany
- Klinikum Rechts Der Isar
München, Germany
- Universitaetsklinikum Tubingen
Tübingen, Germany
- Universitaetsklinikum Ulm
Ulm, Germany
- University of Southern California
Los Angeles, California, United States
- the Parkinsons Institute
Sunnyvale, California, United States
- Pacific Health Research & Education Institute
Honolulu, Hawaii, United States
- the University of Kansas Medical Center
Kansas City, Kansas, United States
- Struthers Parkinson'S Center
Golden Valley, Minnesota, United States
- Feinstein Institute for Medical Research, North Shore-Lij Health System
Manhasset, New York, United States
- Pennsylvania Hospital
Philadelphia, Pennsylvania, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- University of Vermont
Burlington, Vermont, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2012
- Primary completion
- 31 Aug 2016
- Completion
- 31 Dec 2016
- Last update posted
- 29 Sept 2015
- Registered enrollment
- 160
- Registry id
- NCT01560754
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.